NNVC

AMEXStock

NanoViricides, Inc.

$1.16+0.00 (+0.00%)

52-Week Range

$0.85

$2.03

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.27

Volume

289.2K

Avg Volume

274.0K

Performance

+24.73%

-5.69%

-20.00%

YTD

-4.13%

-5.69%

-10.77%

-78.79%

Price Chart

ETF Exposure

NNVC is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	16	$22	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	605	$791	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	344,656	$333K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,812	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	156	$204	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	166,821	$161K	$84.10B	0.05%

About NNVC ETF Exposure

NanoViricides, Inc. (NNVC) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.16. Investors can gain exposure to NNVC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NNVC, sorted by portfolio weight.